OSAKA University Venture Capital
Corporate VCOsaka · Pre-Seed–Growth · 20 people tracked
Also known as 大阪大学ベンチャーキャピタル株式会社
Investment thesis
OUVC operates under Osaka University's vision of being a world-leading innovative university that contributes to social transformation. The firm aims to translate university research results into real-world applications and back ventures born from Osaka University's research seeds, supporting their commercialization to help build a prosperous future society. Its activity spans areas such as life sciences and deep-tech research spinouts, including support for university-originated seeds in fields like sulfur polymers, heart failure treatments, and osteoporosis treatment devices.
Source: firm website, verified Aug 3, 2026.
Team · 20 people
from the firm's website
What they invest in
from 33 of 91 portfolio companiesMedical Devices ×17Healthtech ×16Biotech ×15Deep Tech ×14AI & Machine Learning ×13Digital Health ×9Hardware ×5Cleantech ×3
HQs:Japan×31United States×1
Investments · 91 tracked
founders shown can be your intro pathA-SEEDS is a Shinshu University spin-out developing non-viral gene-modified immune cell therapies, including non-viral CAR-T cell products, to treat pediatric and young-adult cancers, including solid tumors, that lack effective treatments.
BiotechDeep TechHealthtechMedical DevicesMatsumoto, JP
Yozo Nakazawa(Founder & Director; Professor, Department of Pediatrics, Shinshu University)Shigeki Yagyu(Representative Director (CEO))Takuji Achiha(Chief Development Officer)Kiyohito Tani(Chief Operating Officer)
A-wave develops medical devices and related software/hardware products for healthcare applications.
AI & Machine LearningHealthtechMedical Devices大阪市, JP
AIBTRUST is a University of Osaka-originated venture company based in Japan working in the artificial intelligence field.
AI & Machine LearningData & InfrastructureDigital HealthTokyo, JP
森岡 康一(代表取締役 (Representative Director))
Bioworks develops PlaX, a plant-based fiber intended as an alternative to petroleum-derived synthetic fibers, aimed at making the apparel industry more sustainable.
BiotechCircular EconomyNew Materials未記載, JP
坂本 孝治(代表取締役社長 CEO)今井 行弘(取締役会長 (Founder))寺田 貴彦(取締役常務執行役員 CTO)
Celaid Therapeutics develops hematopoietic stem cell expansion technology, including a method to replace albumin with polyvinyl alcohol and to expand human hematopoietic stem cells ex vivo in large quantities.
BiotechDeep TechHealthtechMedical Devices
Nobuyuki Arakawa(Co-founder & Representative Director, President & CEO)Yusuke Inoue(Director, COO & CFO)Asako Uchiyama(Director, CDO (Chief Development Officer))Motoo Watanabe(Co-founder / Advisor (former Chairman & CSO))Hiromitsu Nakauchi(Co-founder)Masatoshi Sakurai(Co-founder)
Crimson Technology is a Japanese company involved in music-related technology, including audio and AI music, with affiliations to Japanese music electronics and metadata industry bodies.
AI & Machine LearningCreator EconomyMedia & EntertainmentTokyo, JP
Kazuo Higa(代表取締役 (Representative Director))
EX-Fusion is a Japanese private company developing laser-based nuclear fusion energy technology, aiming to decarbonize existing energy sources and contribute to carbon neutrality.
CleantechDeep TechEnergyKyoto, JP
Kazuki Matsuo(代表取締役社長 (President & CEO))
GAIA BioMedicine (株式会社ガイアバイオメディシン) develops GAIA-NK, a cell therapy using engineered cells with high cytotoxic activity against solid tumors, based on research from Kyushu University.
BiotechHealthtechMedical DevicesFukuoka, JP
Yoshikazu Yonemitsu(Founder)Kazuyuki Kuramori(Representative Director, President & CEO)Yui Harada(Director & CTO)Daisuke Ara(Director & CFO)
HOIST is an Osaka University-derived biotech venture developing anti-cancer drugs, focusing on novel modalities and mechanisms of action for cancers that lack sufficient treatments.
BiotechDigital HealthHealthtechMedical DevicesWakayama, JP
柿沼千早(代表取締役 (CEO))
HULIX is an Osaka University spinout building 3D spatial AI that uses LiDAR, SLAM, 3D point cloud analysis, and digital twin technology to convert real-world spaces into AI-usable data.
AI & Machine LearningData & InfrastructureDeep TechIoTSuita, JP
Mitsuo Moriya(Representative Director & CEO)Hiromi Yamaguchi(Director)
J-Tec develops, manufactures, and sells high-precision X-ray mirrors ("OsakaMirror") and other optical elements based on ultra-precision machining and metrology, along with ultra-precision polishing equipment for Si, SiC, diamond, and ceramic wafers.
Advanced ManufacturingDeep TechHardwareSemiconductorsOsaka, JP
JEPLAN is a Japanese group focused on recycling and circular economy, working with domestic and international partners under the mission of "circulating all things." It aims to advance a circular economy through recycling technologies and operations across its business sites and factories.
Circular EconomyCleantechClimate TechNew MaterialsTokyo, JP
髙尾 正樹(代表取締役 執行役員社長 (President & CEO))
KOTAI Biotechnologies develops an immune AI platform and big data analysis pipeline that combines artificial intelligence with immunology for antibody and immune-repertoire analysis.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMinoh, JP
山下 和男(共同創業者・代表取締役 (Co-founder & CEO))Kazuo Yamashita(Co-founder & CEO)
LQUOM develops long-distance quantum communication technology and quantum repeaters to enable theoretically unhackable quantum internet for sectors including finance, telemedicine, and defense.
CybersecurityDeep TechQuantum ComputingYokohama, JP
Kazuya Niizeki(Co-founder & CEO)Tomoyuki Horikiri(Co-founder & CSO, Director)
MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesKyoto, JP
Kazuo Miyazaki(代表取締役CEO (Representative Director & CEO))Kazuhisa Fushihara(取締役CFO (Director & CFO))Yasuhiro Natsume(取締役 (Director))
MyImmune develops AI that analyzes adaptive immune repertoire data to identify drug targets, predict patient responses to immunotherapies, and build biomarkers and companion diagnostics.
AI & Machine LearningBiotechDigital Health
PaMeLa develops compact, low-burden medical devices that use artificial intelligence to objectively measure and visualize pain, addressing the reliance on patients' subjective self-reporting.
AI & Machine LearningDigital HealthHealthtechMedical DevicesOsaka, JP
後藤 宏明(代表取締役 (Representative Director))
Restore Vis is a life sciences company founded by a vitreoretinal surgeon and clinician scientist focused on addressing inflammation, aging, neurodegeneration and angiogenesis through translational research from drug discovery to clinical trials.
BiotechDigital HealthHealthtechMedical DevicesTokyo, JP
Dr. Rajendra S. Apte(Paul A. Cibis Distinguished Professor; Vice Chair of Innovation and Translation; Founder)
Revascular Bio develops cell therapy treatments using vascular endothelial stem cells to address diseases caused by vascular dysfunction, including chronic wounds, severe limb ischemia, and genetic blood disorders.
BiotechDeep TechMedical DevicesSuita, JP
Shinsei Omori(Representative Director, President & CEO)
Company that produces complex ceramic components using a stereolithography (slurry-based) 3D printing process, in which ceramic powder is mixed with UV-curable resin, shaped layer by layer with a UV laser, then debinded and sintered.
Advanced ManufacturingHardwareNew MaterialsKusatsu, JP
Tadakatsu Asano(Representative Director & President)
TCN Prime develops medical devices for cardiovascular applications, including innovative catheter systems for treating aortic stenosis and ECMO support.
Deep TechHealthtechMedical DevicesTokyo, JP
小西明英(CEO / Representative Director)岩崎正道(Director / CMO)八木隆浩(Director / CTO)三池信也(Director / CFO)
Alpha Fusion is a Japanese biotechnology company developing targeted alpha therapy drugs based on Astatine-211 (211At) to treat cancer with reduced side effects to healthy tissue.
BiotechDigital Health
J-Pharma is a drug development company focused on SLC transporter-targeted therapies, with its lead LAT1 inhibitor nanvuranlat (JPH203) in a global Phase 3 trial for biliary tract cancer and other candidates addressing cancer, autoimmune, and rare diseases.
BiotechDigital HealthHealthtechMedical DevicesTokyo, JP
𠮷武 益広(代表取締役社長 (Representative Director & President))藤本 裕(取締役CFO)山本 寛(取締役CBO)
ThinkCyte develops diagnostic devices and cellular analysis platforms using imaging flow cytometry and microfluidics technology.
AI & Machine LearningBiotechDeep TechMedical DevicesRedwood City, US
Waichiro(Co-founder & CEO)Sadao(Co-founder & CSO)Issei(Co-founder & Senior Scientific Advisor)Ryoichi(Co-founder)
NexFi Technology Inc. develops, manufactures, and sells high-voltage power equipment using next-generation SiC (silicon carbide) power devices.
CleantechDeep TechEnergyHardwareSemiconductorsOsaka, JP
Takashi Nakamura(代表取締役社長 (President & CEO))
Portfolio news
latest coverage across their companiesRestore Vision · shionogi.com · Apr 15, 2026
Frequently asked questions
- What stage does OSAKA University Venture Capital invest at?
- OSAKA University Venture Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What is OSAKA University Venture Capital's typical check size?
- OSAKA University Venture Capital typically writes checks of $3M – $142M.
- What sectors does OSAKA University Venture Capital focus on?
- OSAKA University Venture Capital focuses on Advanced Manufacturing, Biotech, Deep Tech, Healthtech, Medical Devices, Sector Agnostic.
- Where is OSAKA University Venture Capital located?
- OSAKA University Venture Capital is headquartered in Osaka, JP.
Images
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
UntroD Capital is a deep-tech-focused investment firm that backs research-and-development-driven startups whose innovative technologies address challenges facing the planet and humanity, an approach it terms 'Real Tech'.
Tesi (Finnish Industry Investment Ltd) is a Finnish state-owned investment company that invests directly in companies and as a fund investor, and operates fund-of-funds programs (KRR). It acts as a co-investor across venture, growth, and industrial investments.